Regulus Therapeutics Inc. (RGLS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 12:17PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 145.33M |
| Enterprise Value | 123.96M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.86 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.24 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.55 |
| 52-Week Change 3 | 68.18% |
| S&P500 52-Week Change 3 | 22.64% |
| 52 Week High 3 | 3.7900 |
| 52 Week Low 3 | 1.0800 |
| 50-Day Moving Average 3 | 2.1418 |
| 200-Day Moving Average 3 | 1.5638 |
Share Statistics
| Avg Vol (3 month) 3 | 3.12M |
| Avg Vol (10 day) 3 | 253.21k |
| Shares Outstanding 5 | 65.47M |
| Implied Shares Outstanding 6 | 66.64M |
| Float 8 | 41.55M |
| % Held by Insiders 1 | 1.68% |
| % Held by Institutions 1 | 76.73% |
| Shares Short (Apr 15, 2024) 4 | 6.27M |
| Short Ratio (Apr 15, 2024) 4 | 9.44 |
| Short % of Float (Apr 15, 2024) 4 | 12.18% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 9.59% |
| Shares Short (prior month Mar 15, 2024) 4 | 5.13M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Oct 04, 2018 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Jun 29, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -50.20% |
| Return on Equity (ttm) | -110.27% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -30.88M |
| Net Income Avi to Common (ttm) | -30.04M |
| Diluted EPS (ttm) | -1.5800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 23.77M |
| Total Cash Per Share (mrq) | 0.36 |
| Total Debt (mrq) | 3.1M |
| Total Debt/Equity (mrq) | 14.64% |
| Current Ratio (mrq) | 3.31 |
| Book Value Per Share (mrq) | 1.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26.77M |
| Levered Free Cash Flow (ttm) | -16.93M |
© 2024 Yahoo. All rights reserved.